Harmony Biosciences to Present Narcolepsy Trial Data at European Narcolepsy Days

Harmony Biosciences will present a poster at the 17th European Narcolepsy Days featuring information from its ongoing Phase 3 trials of HBS-301, including ONSTRIDE-1 in narcolepsy and ONSTRIDE-2 in idiopathic hypersomnia.